Unpicking pharma’s reputation in pop culture

Season 03: episode 06

In this week’s episode, Helena is joined by Paul Simms, CEO of Impatient Health, to delve deeper into GOLD’s recent cover feature on reframing pharma’s bad boy reputation.

They chat about the current state of pharma’s reputation and the influence of the media and pop culture on this, the ways in which pharma can recover and bolster its reputation, and more.


And in ‘news you might have missed’, Helena discusses the latest global awareness campaign from Leo Pharma, the ABPI’s recent survey on pharma and academia collaboration and a new Marvel comic strip features Pfizer’s COVID-19 vaccination efforts in the US.


A little more on GOLD’s guest…


A well-known face on the pharma conference circuit, Paul Simms, CEO of Impatient Health, is passionate about provoking meaningful change in order to realise the huge, unfulfilled potential of the industry and life sciences as a whole. Perhaps best known for his 17 years at the helm of eyeforpharma, which was acquired by Reuters in 2019, he created some of the pharmaceutical industry’s largest and most influential events. In 2020, he set up Impatient Health – an industry think tank and consultancy that aims to help pharma become more ambitious and creative.

Additional resources


If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Click here to subscribe to the weekly newsletter for more insights from GOLD.